BACKGROUND: This study examined the effects of supervised and home-based exercise interventions on changes in metabolic syndrome (MetS) according to breast cancer risk (high vs low) in black women enrolled in the Focused Intervention on Exercise to Reduce Cancer (FIERCE) trial. METHODS: Postmenopausal, obese, metabolically unhealthy black women, 45 to 65 years old, were randomized to supervised aerobic exercise (73 women), home-based walking-based exercise (69 women), or a control arm (71 women). Participants in the exercise arms underwent a 6-month intervention with study assessments conducted at the baseline and 6 months. The primary outcome measure was MetS (fasting glucose, waist circumference, blood pressure, serum triglycerides, and high-density lipoprotein [HDL]). The intervention effects on MetS, stratified by breast cancer risk as measured by the family history of breast cancer and model-based projected breast cancer risk, were examined with intent-to-treat analyses using generalized estimating equation models. RESULTS: Among women with a family history of breast cancer, the exercise arms had lower mean MetS z scores, which suggested an improvement in the metabolic profile, than controls at 6 months (controls, 1 0.55; home-based arm, -0.97, P <.01; supervised arm, -0.89, P <.01). Stratified analyses by projected breast cancer risk suggested similar but statistically nonsignificant findings, with those at high risk having more favorable changes in the MetS z score in the exercise arms versus the control arm. These changes were primarily attributable to changes in blood pressure, triglycerides, and HDL. CONCLUSIONS: Short-term aerobic activity regimens may improve the metabolic profile and thereby reduce breast cancer risk in obese, metabolically unhealthy black women at high risk for cancer. Cancer
INTRODUCTION
Metabolic syndrome (MetS), characterized by abdominal obesity, high blood glucose levels, impaired glucose tolerance, dyslipidemia, and hypertension, has been suggested to play a role in breast carcinogenesis. [1] [2] [3] [4] Black women are 20% more likely to have MetS than white women and have a higher prevalence of certain MetS components, such as abdominal obesity, elevated fasting glucose, and hypertension. [4] [5] [6] Being obese and metabolically unhealthy is associated with the highest risk for breast cancer. 7 This risk is mediated through interrelated pathways, such as those involving insulin, estrogen, cytokines, and growth factors. [1] [2] [3] 7 Breast cancer is the most common cancer among black women with incidence and mortality rates of 125.5 and 29.5 cases per 100,000, respectively. The incidence in black women has continued to rise, 7 from approximately 90 per 100,000 in the 1970s to more than 120 per 100,000 in the 2010-2014 period, in part because of the rising prevalence of obesity and MetS in this group. 8 As a result, numerous expert panel guidelines have recommended lifestyle modifications, such as increased physical activity, as an effective intervention for reducing the risk of breast cancer. 9, 10 These approaches, targeted at obese, metabolically unhealthy women at high risk for breast cancer because of a family history or other hormonal risk factors, such as those determined by the National Cancer Institute's breast cancer risk assessment tool for black women, which was developed with data from the Women's Contraceptive and Reproductive Experiences (CARE) study, 11 could lead to the most gains in breast cancer prevention. Although a recent meta-analysis of trials of aerobic exercise among metabolically unhealthy women reported an exercise-associated improved metabolic profile, data from controlled trials of exercise among black women at high risk for breast cancer are not available. 12 In addition, most of the interventions studied have been facility-based and/or intensive, and it is unclear whether unsupervised, home-based interventions might have outcomes similar to those of supervised, facility-based interventions.
In the current randomized controlled trial, we investigated the effects of short-term supervised and homebased aerobic exercise interventions on changes in MetS and their individual components according to the family history of breast cancer and predicted risk of breast cancer with the CARE model in obese, metabolically unhealthy black women who were enrolled in the Focused Intervention on Exercise to Reduce Cancer (FIERCE) study. To our knowledge, this is the first study to investigate the effect of an exercise intervention on MetS by breast cancer risk in obese, postmenopausal black women.
MATERIALS AND METHODS
The FIERCE study was a 6-month, 3-arm randomized controlled trial of 2 moderate-intensity exercise interventions (compared with a control group) among obese (waist circumference > 35 inches), physically inactive, postmenopausal black women aged 45 to 65 years. The randomized controlled trial was conducted between 2012 and 2016 at the community-based office of the Georgetown Lombardi Comprehensive Cancer Center with approval of the institutional review board. Written informed consent was obtained from each participant. The FIERCE study is described in detail elsewhere. 13 Briefly, 213 eligible participants were randomly assigned to 1 of 3 clinical trial arms: 1) a supervised, facility-based aerobic exercise intervention with a goal of 150 min/wk of moderate-intensity exercise (three 50-minute sessions per week) at the community-based office (n 5 73); 2) a home-based exercise intervention with a goal of 7000 to 10,000 steps per day (equivalent to 150 min/wk of moderate-intensity activity) 14 as measured by a pedometer through brisk walking or slow jogging (n 5 69); and 3) a wait-listed control group whose participants were asked to maintain their baseline daily activities for the duration of the study (n 5 71). Participants in the supervised group exercised at a heart rate range within 45% to 65% of their maximum oxygen uptake, as determined by baseline treadmill testing. Participants wore heart rate monitors to ensure moderate exercise intensity. Participants in the home-based group exercised at an exercise intensity in the range of 11 to 14 (moderate) on the 20-point Rating of Perceived Exertion scale. Participants were taught how to determine moderate exercise intensity with the Rating of Perceived Exertion scale during the baseline visit.
Exclusion criteria included a history of cancer (except for nonmelanoma skin cancer), diabetes, a < 1.40% projected risk of breast cancer as determined by the CARE model, current regular exercise, current enrollment in another clinical trial or weight-loss program, and an inability to commit to the intervention schedule. Before randomization, all participants completed the Physical Activity Readiness Medical Examination. 15 Random assignments were generated by the study statistician (K.M.) with a computer-based random-number generator. Investigators and staff were blinded to the assignment. All study measures were collected at baseline and 6-month time points by trained personnel.
Blood Sample Collection and Processing
Fasting baseline venous blood samples were drawn in the morning. During follow-up visits, fasting morning blood samples were drawn 16 to 24 hours after the most recent exercise session for participants in the intervention arms to minimize the measurement of acute effects of exercise. 16 Samples were processed within 2 hours and stored at -708C.
Metabolic Variables and Assays
Waist circumference was measured at the level of the navel with a measuring tape and was recorded in centimeters. Fasting glucose was analyzed in the stored serum samples with the Ortho Clinical Diagnostics Vitros 5.1 FS Chemistry System glucose oxidase slide method. Intra-and interassay coefficients of variation for serum glucose were 1.2% to 1.5%. Systolic and diastolic blood pressures were measured after 10 minutes of rest with the participant in a seated position by trained personnel, and they were repeated again after 10 minutes. The average of the 2 measures was used in the analysis. The mean arterial pressure was calculated as follows:
Mean arterial pressure 5 ½Systolic blood pressure 1 ðDiastolic blood pressure 3 2Þ=3 Serum lipids were analyzed on the Ortho Clinical Diagnostics Vitros 5.1 FS Chemistry System platform with a multilayered, enzymatic slide method. Intra-and interassay coefficients of variation were 1.5% to 1.8% for total cholesterol, 2.9% to 3.0% for high-density lipoprotein (HDL) cholesterol, 0.9% to 1.4% for triglycerides, and 1.8% to 3.7% for calculated LDL.
MetS Criteria and MetS z Score
According to the US National Cholesterol Education Program Adult Treatment Panel III definition, 17 MetS was defined as 3 or more of the following 5 factors: waist circumference 88 cm, fasting glucose 100 mg/dL, systolic blood pressure 130 mm Hg or diastolic blood pressure 85 mm Hg, triglycerides 150 mg/dL, and HDL cholesterol < 50.
In addition to the dichotomous MetS, a continuous MetS z score was also calculated on the basis of equations described previously. [18] [19] [20] [21] The modified z score was calculated with individual subject data, the Adult Treatment Panel III criteria, and standard deviations for each MetS component based on data from all participants at the baseline. The equation used to calculate the MetS z score was as follows: The family history of breast cancer in a first-degree relative (ie, mothers, daughters, and sisters) was assessed through self-report.
CARE Model
Five-year individual invasive breast cancer risk was assessed with the CARE model. The CARE model was used to project the absolute risk of breast cancer because it has been shown to perform better among black women than the Gail model. 11, 22 The CARE model uses data on current age, race, age at menarche, the number of firstdegree relatives with breast cancer, the number of breast biopsies, and atypical hyperplasia on biopsy to determine breast cancer risk. 11 On the basis of prior publications, a 5-year risk of 1.67% or higher was considered high.
Covariates
Information on demographic and lifestyle factors, including smoking, was collected through self-reported questionnaires. Exercise behavior was assessed with the International Physical Activity Questionnaire, a structured interview that measures a person's time spent engaging in exercise over a 7-day period. 23 A metabolic equivalent task (MET) score was assigned to each activity on the basis of its energy cost. 24 To calculate the amount of energy expended, the time spent at each activity in hours per week was multiplied by its MET score and then summed over all activities to yield total MET-hours per week. The usual dietary intake was assessed with the Block 2005 Food Frequency Questionnaire. 25 Anthropometric measures of height, weight, and waist and hip circumference were also collected.
Statistical Analysis
An intention-to-treat analysis was performed for all participants who were enrolled and randomly allocated to 1 of the clinical trials arms. The intervention effects were evaluated with generalized estimating equation models considering the MetS components and the z score as repeated measures. The models included main effects of intervention and time as well as their interaction term and were adjusted for baseline values of the outcome studied. All statistical tests were 2-sided with the level of significance set at P 5 .05. Statistical analyses were performed with SAS software (version 9.3; SAS Institute, Cary, North Carolina).
RESULTS

Participants
Depicted in Figure 1 is the Consolidated Standards of Reporting Trials diagram for the FIERCE study. A total of 1521 black women were screened; 430 (28%) were initially eligible for the office visit screening. The study comprised 213 women randomized to the 3 arms of the study: supervised (n 5 73), home-based (n 5 69), and control (n 5 71). At the end of 6 months of follow-up, the retention rate was 73%. Among participants who completed the study, adherence to the interventions -defined as completing 80% or more of the exercise target set at the baseline -was similar in the 2 exercise arms (supervised, 65%; home-based, 68%). Adherence to interventions did not differ by family history or projected breast cancer risk in either arm.
Baseline characteristics were similar between the 3 arms and are shown in Table 1 . The mean age of the participants was 58.3 years, with more than 90% having a high school or higher education. Participants had low mean exercise levels at the baseline (4 MET-h/wk) and had a high daily caloric intake (2000 kcal). A family history of breast cancer in a first-degree relative was reported by 40% of the participants, and the average projected 5-year absolute risk of breast cancer based on the CARE model in this group was 1.85.
Exercise Intervention Effects on MetS
In intention-to-treat analyses, the proportion of participants with MetS was lower at the 6-month intervention than the baseline in the exercise arms but not in the control arm. In comparison with the 8% increase in MetS among participants in the control arm at 6 months, those in the supervised and home-based groups had 4% (P 5 .04) and 23% decreases (P < .01) in the proportion with MetS. Six-month changes from the baseline in the levels of MetS components and MetS z scores for the 3 study arms by family history of breast cancer are presented in Table 2 . Among women with a family history of breast cancer, women in the supervised and home-based arms had lower mean MetS z scores, which suggested an improvement in the metabolic profile, in comparison with the control arm, which had higher z scores at the 6-month follow-up than the baseline (control, 1 0.55; home-based, -0.97, P < .01; supervised, -0.89, P < .01). These changes were primarily driven by statistically significant decreases in mean arterial pressure and increases in serum HDL in the supervised arm and by changes in serum triglycerides and serum HDL in the home-based arm in comparison with the control arm, in which the mean arterial pressure and triglycerides increased and HDL decreased over the 6-month follow-up. None of the changes in the MetS components or the z score at the 6-month follow-up were significantly different between the 3 groups in women without a family history of breast cancer. Changes in the proportion of women with MetS from the baseline were also significantly lower in the supervised and home-based arms in comparison with the control arm among women with a family history of breast cancer (control, 1 1%; supervised, 0%, P 5 .22; home-based, -34%, P < .01) but not among those without a family history (control, 1 13%; supervised, -7%, P 5 .25; home-based, -7%, P 5 .09; Fig. 2 ).
Exercise Intervention Effects on MetS by Projected Breast Cancer Risk
Stratified analyses by projected breast cancer risk, using the CARE model (high risk 1.67; low risk < 1.67), suggested findings similar to those from stratification by Abbreviations: FIERCE, Focused Intervention on Exercise to Reduce Cancer; HL, high-density lipoprotein; P C-H , probability for the home-based group versus the control group; P C-S , probability for the supervised group versus the control group; P H-S , probability for the home-based group versus the supervised group; SD, standard deviation; SE, standard error. a P values are presented for comparing the changes; adjustments have been made for the baseline values of the outcomes.
family history, with those at high risk having more favorable changes in the MetS z score in the exercise arms (vs the control arm) than those with a risk score below 1.67 (Supporting Table 1 ). However, these changes for z scores were not statistically significant between the control and exercise intervention arms (control, -0.03; home-based, -0.78, P 5 .11; supervised, -0.80, P 5 .08). When MetS was analyzed as a dichotomous variable, among participants with a low projected breast cancer risk score at the baseline, women in both exercise arms had a lower proportion of MetS in comparison with controls (control, 1 12%; supervised, -13%, P 5 .04; homebased, -20%, P 5 .09). However, in the high projected breast cancer risk group, women in the home-based arm had lower proportions of MetS at 6 months versus the baseline, but this was not true for women in the supervised and control groups (control, 1 3%; supervised, 1 11%, P 5 .55; home-based, -25%, P < .01; Fig. 3) .
DISCUSSION
This community-based exercise intervention trial among postmenopausal, obese, metabolically unhealthy black women examined the effectiveness of a supervised exercise intervention and a home-based exercise intervention in comparison with controls with respect to MetS outcomes by breast cancer risk. Women in the home-based intervention arm who had a family history of breast cancer or were at high risk (CARE score 1.67) had statistically significant improvements in their MetS profiles in comparison with those with no family history and in a low-risk group. Furthermore, the changes in metabolic profile were primarily attributed to reductions in blood pressure and triglycerides at 6 months.
It has been suggested that weight-loss and exercise interventions are most successful when they are focused on medically at-risk populations. 26 However, exercise or lifestyle change trials among medically at-risk black women or those with comorbidities are limited. [27] [28] [29] In addition, none of the trials have focused on obese, metabolically unhealthy black women at high risk for cancer, and none have focused exclusively on exercise. To the best of our knowledge, this is the first trial to suggest that short-term moderate aerobic exercise might reduce the risk of breast cancer by altering the metabolic profile among black women at high risk, but not low risk, for breast cancer. Our results seemed to suggest a greater improvement in MetS among home-based participants than supervised-group participants. The reasons for this finding are unclear, but it is possible that they might be related to the longer duration of moderate-intensity activity for home-group participants (7000-10,000 steps per day) versus supervised-group participants (150 minutes of supervised aerobic exercise per week) for the same effective dose of aerobic activity. However, the role of chance in these findings cannot be ruled out, and replication in future studies is warranted.
Blacks in weight-loss trials tend to lose less weight on average than white participants. 27, 29, 30 However, when stratified by family history or projected breast cancer risk, black women at higher risk were more likely to show reductions in waist circumference than those at lower risk in the exercise and control groups. The largest reductions were seen for high-risk participants in the supervised exercise group, even though comparisons between the groups were not statistically significant. Changes in the body mass index were similar to changes in waist circumference, and none of the comparisons between intervention and control arms were statistically significant.
Improvements in metabolic profile in the exercise groups among high-risk participants were primarily driven by reductions in blood pressure and triglyceride levels and an increase in HDL levels. Although a recent meta-analysis suggested similar changes in blood pressure with exercise as seen in our study, 31 the differences between those at high risk and those at low risk for breast cancer have not been reported previously. Supervisedgroup participants at high risk for breast cancer had the greatest reductions in blood pressure in comparison with the control group. In a meta-analysis of the role of exercise in serum lipids that included 51 studies, Mann et al 32 reported that 12 weeks or more of aerobic exercise resulted in a mean increase in HDL levels of 4.6% and a decrease in triglyceride levels of 3.7%. Results from our study are much stronger for high-risk participants randomized to the home-based group for triglycerides (15% decrease) and to both exercise groups for HDL (10% increase) in comparison with the baseline. High-risk control-group participants had unfavorable changes at 6 months for both triglycerides and HDL.
The biological mechanisms that underlie our findings of a more favorable metabolic response to exercise among those at high risk for breast cancer have not been studied, but a possible role for hormones such as insulinlike growth factor 1 (IGF-1) can be hypothesized. The association of IGF-1 with MetS, including deregulated lipid metabolism, cardiovascular disease, and diabetes, is well established. 33 IGF-1 has multiple physiological effects, including effects on tissue growth and development, proliferative effects, effects on lipid metabolism, prosurvival/anti-aging effects, anti-inflammatory effects, and antioxidant effects. [34] [35] [36] A correlation between IGF-1 and increasing MetS markers, including blood pressure, has been demonstrated in the Framingham study. 37 There is also ample evidence to support the role of IGF-1 in breast cancer initiation and progression. 38 Results from a pooled analysis of 17 prospective cohort studies have shown a strong association between circulating IGF-1 and hormone-positive breast cancer risk in postmenopausal women. 39 IGF-1 levels have also been positively associated with women at increased genetic risk for breast cancer (BRCA gene mutation carriers). 40 This suggests a potential biologic rationale for our findings.
The strengths of our study include a fairly large trial of exercise among black women at high risk for breast cancer, an understudied group in cancer prevention trials. Other advantages of our trial include the targeting of the trial to obese, metabolically unhealthy women, the testing of 2 different exercise regimens, biomarker-based measurements for MetS, and stratified analyses of trial effects by breast cancer risk status. Limitations include a 27% dropout rate, which reduced the effective sample size; a lack of adherence in the wait-listed control group (eg, selfreported exercise in all 3 groups increased at 6 months vs the baseline and was similar in all 3 groups [data not shown]); and a lack of generalizability of the study findings to nonobese or metabolically healthy black women. It is also possible that women in the high-risk groups exercised more than those in the low-risk groups. However, there was no difference by risk status in adherence within the intervention groups. Moreover, women were eligible only if they had a >1.40% projected 5-year absolute risk of breast cancer and were told that they were at higher estimated risk for breast cancer than average-risk women of their age and race at the start of the study.
The findings from the current study strongly suggest that black women at increased risk for breast cancer are ideal targets for cancer prevention exercise interventions. Furthermore, moderate, short-term aerobic activity regimens, both home-based and supervised, may prove to be impactful in improving the metabolic profile and reducing the risk of breast cancer even without weight reduction or changes in abdominal obesity in this high-risk population. Studies on biomarkers of the insulin pathway are warranted to determine mechanisms that mediate the effect of exercise on MetS among women at high risk for breast cancer.
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